Decibel Therapeutics Inc. (DBTX)
NASDAQ: DBTX
· Real-Time Price · USD
4.91
-0.04 (-0.81%)
At close: Sep 22, 2023, 10:00 PM
Decibel Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 39.8M | 38.06M | 34.61M | 36.68M | 56.45M | 10.78M | 36.45M | 51.41M | 37.69M | 52.24M |
Short-Term Investments | 38.5M | 49.88M | 69.95M | 75.26M | 69.2M | 123.66M | 112.29M | 92.48M | 118.08M | 129.84M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 5M | 13.55M | 28.49M | 28.83M | 9M |
Other Long-Term Assets | 934K | 924K | 924K | 1.06M | 1.16M | 1.13M | 1.13M | 1.13M | 1.13M | 1.38M |
Receivables | n/a | 4.4M | n/a | 10M | 10M | 10M | 11.4M | 3.14M | 1.72M | 4.24M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 2.15M | 3.53M | 3.47M | 4.34M | 5.76M | 6.8M | 4.04M | 2.83M | 3.81M | 4.42M |
Total Current Assets | 80.45M | 95.87M | 108.03M | 126.29M | 141.41M | 151.24M | 164.19M | 149.87M | 161.3M | 190.73M |
Property-Plant & Equipment | 13M | 13.66M | 14.42M | 14.93M | 15.71M | 16.41M | 5.61M | 5.8M | 5.63M | 5.97M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 13.94M | 14.59M | 15.34M | 15.99M | 16.87M | 22.54M | 20.29M | 35.42M | 35.59M | 16.35M |
Total Assets | 94.39M | 110.45M | 123.37M | 142.27M | 158.28M | 173.78M | 184.48M | 185.29M | 196.9M | 207.09M |
Account Payables | 617K | 1.28M | 1.06M | 3.03M | 1.92M | 1.21M | 4.01M | 1.81M | 2.14M | 1M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 13.8M |
Short-Term Debt | 3.66M | 3.59M | 3.59M | 3.62M | 3.65M | 3.68M | 213K | 208K | 201K | 197K |
Other Current Liabilities | 22.3M | 18.31M | 17.79M | 16.72M | 17.31M | 13.22M | 16.31M | 14.48M | 14.29M | 197K |
Total Current Liabilities | 26.58M | 23.18M | 22.44M | 23.37M | 22.87M | 18.11M | 20.54M | 16.5M | 16.64M | 15.19M |
Long-Term Debt | 9.18M | 9.81M | 10.47M | 11.1M | 11.73M | 12.33M | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 5.31M | 7.62M | 8.67M | 10.98M | 11.82M | 15.23M | 22.25M | 14.63M | 10.85M | 11.63M |
Total Long-Term Liabilities | 14.5M | 17.43M | 19.14M | 22.09M | 23.55M | 27.56M | 22.25M | 14.63M | 10.85M | 11.63M |
Total Liabilities | 41.08M | 40.61M | 41.58M | 45.46M | 46.42M | 45.66M | 42.79M | 31.13M | 27.48M | 26.82M |
Total Debt | 12.85M | 13.4M | 14.05M | 14.72M | 15.38M | 16.01M | 213K | 208K | 201K | 197K |
Common Stock | 25K | 25K | 25K | 25K | 25K | 25K | 25K | 25K | 25K | 25K |
Retained Earnings | -308.97M | -290.82M | -277.52M | -261.58M | -245.57M | -228.53M | -214.51M | -201.61M | -185.21M | -173.56M |
Comprehensive Income | -35K | -61K | -223K | -503K | -588K | -527K | -132K | 8K | 5K | -21K |
Shareholders Equity | 53.31M | 69.84M | 81.79M | 96.81M | 111.86M | 128.12M | 141.69M | 154.16M | 169.41M | 180.27M |
Total Investments | 38.5M | 49.88M | 69.95M | 75.26M | 69.2M | 128.66M | 125.84M | 120.97M | 146.91M | 138.84M |